ASB Consultores’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $281K | Buy |
722
+198
| +38% | +$77K | 0.19% | 94 |
|
|
2025
Q1 | $228K | Buy |
+524
| New | +$228K | 0.15% | 99 |
|
|
2024
Q4 | – | Sell |
-765
| Closed | -$398K | – | 218 |
|
|
2024
Q3 | $398K | Buy |
765
+208
| +37% | +$108K | 0.16% | 102 |
|
|
2024
Q2 | $302K | Sell |
557
-92
| -14% | -$49.9K | 0.11% | 135 |
|
|
2024
Q1 | $337K | Buy |
+649
| New | +$337K | 0.09% | 183 |
|
|
2023
Q1 | – | Sell |
-818
| Closed | -$420K | – | 198 |
|
|
2022
Q4 | $420K | Buy |
818
+86
| +12% | +$44.1K | 0.17% | 88 |
|
|
2022
Q3 | $333K | Hold |
732
| – | – | 0.16% | 105 |
|
|
2022
Q2 | $353K | Buy |
732
+15
| +2% | +$7.23K | 0.15% | 91 |
|
|
2022
Q1 | $352K | Buy |
717
+219
| +44% | +$108K | 0.15% | 128 |
|
|
2021
Q4 | $231K | Buy |
+498
| New | +$231K | 0.11% | 199 |
|